Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (161-170 of 458) with videos related to

Pageof 46
Sort By:
Plos Medicine|April 26, 2007
XDR-TB in South Africa: detention is not the priorityEric Goemaere, Nathan Ford, Daniel Berman, et al.
Plos Medicine|June 28, 2007
HIV prevention, care, and treatment in two prisons in ThailandDavid Wilson, Nathan Ford, Verapun Ngammee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic reviewNathan Ford, Francois Venter, Cadi Irvine, et al.
AIDS (London, England)|September 25, 2007
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandNathan Ford, David Wilson, Gabriela Costa Chaves, et al.
Lancet (London, England)|December 4, 2009
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trialsNathan Ford, Jean B Nachega, Mark E Engel, et al.
Journal of the International AIDS Society|January 23, 2014
Impact of point-of-care CD4 testing on linkage to HIV care: a systematic reviewElke Wynberg, Graham Cooke, Amir Shroufi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 4, 2014
Task shifting for the delivery of pediatric antiretroviral treatment: a systematic reviewMartina Penazzato, Mary-Ann Davies, Tsitsi Apollo, et al.
AIDS (London, England)|April 25, 2012
The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited settingEdward J Mills, Celestin Bakanda, Josephine Birungi, et al.
Journal of the International AIDS Society|December 4, 2012
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic reviewKatharina Kranzer, Darshini Govindasamy, Nathan Ford, et al.
AIDS (London, England)|June 5, 2014
Does pregnancy affect the pharmacokinetics of efavirenz?Andrew Hill, Nathan Ford, Marta Boffito, et al.
Pageof 46

Showing results (161-170 of 458) with videos related to

Sort By:
Pageof 46
Plos Medicine|April 26, 2007
XDR-TB in South Africa: detention is not the priorityEric Goemaere, Nathan Ford, Daniel Berman, et al.
Plos Medicine|June 28, 2007
HIV prevention, care, and treatment in two prisons in ThailandDavid Wilson, Nathan Ford, Verapun Ngammee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic reviewNathan Ford, Francois Venter, Cadi Irvine, et al.
AIDS (London, England)|September 25, 2007
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandNathan Ford, David Wilson, Gabriela Costa Chaves, et al.
Lancet (London, England)|December 4, 2009
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trialsNathan Ford, Jean B Nachega, Mark E Engel, et al.
Journal of the International AIDS Society|January 23, 2014
Impact of point-of-care CD4 testing on linkage to HIV care: a systematic reviewElke Wynberg, Graham Cooke, Amir Shroufi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 4, 2014
Task shifting for the delivery of pediatric antiretroviral treatment: a systematic reviewMartina Penazzato, Mary-Ann Davies, Tsitsi Apollo, et al.
AIDS (London, England)|April 25, 2012
The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited settingEdward J Mills, Celestin Bakanda, Josephine Birungi, et al.
Journal of the International AIDS Society|December 4, 2012
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic reviewKatharina Kranzer, Darshini Govindasamy, Nathan Ford, et al.
AIDS (London, England)|June 5, 2014
Does pregnancy affect the pharmacokinetics of efavirenz?Andrew Hill, Nathan Ford, Marta Boffito, et al.
Pageof 46